➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Johnson and Johnson
Harvard Business School
Colorcon
Mallinckrodt

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Children's Cetirizine Hydrochloride Hives Relief patents expire, and when can generic versions of Children's Cetirizine Hydrochloride Hives Relief launch?

Children's Cetirizine Hydrochloride Hives Relief is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Athem, Aurobindo Pharma, Cypress Pharm, Lannett Co Inc, Perrigo R And D, Pharm Assoc, Ranbaxy Labs Ltd, Taro, Torrent, Tris Pharma Inc, Jubilant Generics, and Sun Pharm. and is included in fifteen NDAs.

The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Children's Cetirizine Hydrochloride Hives Relief

A generic version of CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.

  Start Trial

Summary for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Drug patent expirations by year for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Recent Clinical Trials for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hamad Medical CorporationPhase 1
Stefania La Grutta, MDPhase 4
Medical Universtity of LodzPhase 4

See all CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF clinical trials

US Patents and Regulatory Information for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090378-001 May 9, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo R And D CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090254-001 Apr 9, 2008 OTC No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090750-001 Feb 2, 2010 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Colorcon
Express Scripts
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.